AIDSVu is an interactive online mapping tool that visualizes the impact of the HIV epidemic on communities across the United States to increase disease awareness and promote data-driven public health decision-making. AIDSVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc. and the Center for AIDS Research at Emory University (CFAR). The site utilizes data from the Centers for Disease Control and Prevention (CDC), local health departments, and other high-quality sources to allow users to explore the HIV epidemic at the state-, county-, and ZIP Code-levels. The map visualizes HIV-related data by race/ethnicity, sex, age, and transmission category, and shows how HIV is related to various social determinants of health, such as high school education, poverty, and housing.
AIDSVu allows users to locate services for HIV prevention, testing, and care, and also includes NIH-funded HIV prevention, vaccine, and treatment trial locations. In addition, for the nine states in the Deep South, users can locate services for stigma reduction, overdose prevention/reversal, harm reduction, and trauma-informed care. The site also has data pages with profiles for approximately 50 U.S. cities, 48 counties with the highest burden of new HIV diagnoses that are prioritized for Phase 1 of Ending the HIV Epidemic: A Plan for America initiative, 50 states, DC, Puerto Rico, 4 regions, and the nation, offering easy-to-understand, printable snapshots that summarize the impact of HIV and other sexually transmitted diseases.
Now in its 11th year, AIDSVu continues to expand the data, maps, and tools available on its main website, as well as on Powered by AIDSVu projects that visualize public health data. In 2015, the inaugural Powered By AIDSVu project, HIVContinuum.org, was released as a proof of concept to map outcomes across five stages of the HIV care continuum. AIDSVu has now expanded on this model to map more than 40 states and Washington, DC at the state-level, as well as over 35 cities at ZIP Code-level across the U.S. In 2017, the second Powered By AIDSVu project, HepVu.org, was established to visualize the first standardized state-level estimates of Hepatitis C prevalence across the U.S.
The project is led by Patrick Sullivan, PhD, Professor of Epidemiology and Co-Director of the CFAR Prevention Science Core. Dr. Sullivan worked in HIV/AIDS surveillance for 12 years at U.S. Centers for Disease Control and Prevention (CDC), including five years as a Branch Chief overseeing HIV/AIDS surveillance activities. Dr. James Curran, Dean of the Rollins School of Public Health at Emory University and Co-Director of the Emory CFAR, is the Chair of the Advisory Committee for the project. AIDSVu receives ongoing support and guidance from the following groups:
- The AIDSVu Advisory Committee, which consists of key stakeholders who provide oversight and guidance for the project;
- The AIDSVu Technical Advisory Group, which consists of HIV surveillance technical experts who provide input regarding data and technical issues; and,
- The AIDSVu Prevention and Treatment Advisory Committee, which consists of HIV prevention professionals working in health departments across the country who provide input on maximizing AIDSVu’s value for prevention efforts.
The development of AIDSVu was guided by the following HIV/AIDS experts:
- Principal Scientist: Patrick Sullivan, DVM, PhD, Professor, Department of Epidemiology, Rollins School of Public Health, Emory University
- Scientist: Amanda D. Castel, MD, MPH, AAHIVS, AIDSVu Scientist and Professor, Department of Epidemiology, Milken Institute School of Public Health, George Washington University
AIDSVu Advisory Committee
- Gregg Alton, Former Chief Patient Officer, Gilead Sciences, Inc.
- James Curran, MD, Co-Director and Principal Investigator of the Emory Center for AIDS Research
- Nanette Benbow, Senior Policy Advisor and Research Assistant Professor, Northwestern University, Feinberg School of Medicine
- Guillermo Chacon, President, Latino Commission on AIDS
- Chari Cohen, DrPH, MPH, President of Hepatitis B Foundation
- Demetre Daskalakis, MD, MPH, Director of the Division of HIV/AIDS Prevention, CDC
- Carlos del Rio, MD, Hubert Professor and Chair of the Department of Global Health at the Rollins School of Public Health and Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine, co-Director of the Emory Center for AIDS Research (CFAR)
- Carl Dieffenbach, PhD, Director, Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases, National Institutes of Health
- Judith Feinberg, MD, Professor, Behavioral Medicine & Psychiatry, WVU School of Medicine
- Evelyn Foust, MPH, CPM, Branch Head, Communicable Diseases, North Carolina Division of Public Health
- Kevin Frost, Chief Executive Officer, amfAR
- Jennifer Kates, PhD, Vice President and Director of Global Health & HIV Policy, Kaiser Family Foundation
- Stephen Lee, MD, Executive Director, NASTAD
- Marsha Martin, DSW, Prior Director, Urban Coalition for HIV/AIDS Prevention Services
- Henry Masur, MD, Chief, Critical Care Medicine Department, NIH Clinical Center
- Jesse Milan, Jr., JD, President and CEO, AIDS United
- Gregorio Millett, MPH, Vice President and Director, Public Policy, amFAR
- Michael Mugavero, MD, MHSc, Associate Professor, Division of Infectious Diseases, University of Alabama at Birmingham, School of Medicine
- Stacey Trooskin, MD, PhD, MPH, Chief Medical Officer of Philadelphia FIGHT Community Health Centers and Clinical Assistant Professor of Medicine at University of Pennsylvania
- Michael Ninburg, Executive Director Emeritus, Hepatitis Education Project
- Rekha Ramesh, Executive Director, Head of Public Policy, Gilead Sciences
- Ron Valdiserri, MD, MPH, Professor, Department of Epidemiology, Rollins School of Public Health, Emory University, Former Deputy Assistant Secretary for Health, Infectious Diseases, U.S. Department of Health and Human Services
- Su Wang, MD, MPH, Medical Director for Center for Asian Health & Viral Hepatitis Programs at Saint Barnabas Medical Center and President of World Hepatitis Alliance
- Carolyn Wester, MD, MPH, Director, Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, CDC
AIDSVu Technical Advisory Group
- Kathleen Brady, MD, PhD, Director of HIV Epidemiology for the Philadelphia Department of Public Health
- Colby Cohen, MPH, Medical Health Care Program Analyst, HIV/AIDS Section, Bureau of Communicable Diseases, Florida Department of Health
- Natalie Cramer, Senior Director, Prevention, Health Care Access, and Policy, National Alliance of State & Territorial AIDS Directors
- Virginia Takeuchi, Supervising Epidemiologist, HIV Surveillance, Division of HIV/STD Programs, Los Angeles County Department of Public Health
- Jeff Lauritsen, HIV/AIDS Epidemiologist, City of Chicago Department of Public Health
- Eve Mokotoff, Managing Director, HIV Counts, LLC
- Anna Satcher-Johnson, Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention, HIV Incidence and Case Surveillance Branch
- Pamela Klein, PhD, Branch Chief, Evaluation, Analysis, and Dissemination Branch, Division of Policy and Data, HIV/AIDS Bureau, Health Resources and Services Administration
- Shelita Merchant, PhD, Branch Chief, Data Management and Analysis Branch, Division of Policy and Data, HIV/AIDS Bureau, Health Resources and Services Administration
AIDSVu Prevention and Treatment Advisory Committee
- Jenna Gettings, DVM MPH, Director HIV Epidemiology Section, Georgia Department of Public Health
- Vipul Shukla, MPH, Partner Services Coordinator, Wisconsin Department of Health Services, HIV Program
- Margaret Vaaler, PhD, Epidemiology and Supplemental Projects Group Manager, TB/HIV/STD Epidemiology and Surveillance Branch Texas Department of State Services
